Schor S L, Ellis I, Dolman C, Banyard J, Humphries M J, Mosher D F, Grey A M, Mould A P, Sottile J, Schor A M
Department of Dental Surgery and Periodontology, Dental School, University of Dundee, UK.
J Cell Sci. 1996 Oct;109 ( Pt 10):2581-90. doi: 10.1242/jcs.109.10.2581.
Nanomolar concentrations of native fibronectin and its RGDS-containing cell-binding domain have previously been reported to stimulate fibroblast migration in the transmembrane (or 'Boyden chamber') assay; in contrast, the gelatin-binding domain (GBD) of fibronectin has consistently been reported to be devoid of migration-stimulating activity in this assay. We have examined the effects of fibronectin and several of its purified functional domains on the migration of human skin fibroblasts in what is presumably a more physiologically relevant assay involving the movement of cells into a 3-D matrix of native type I collagen fibrils. We report that: (a) femtomolar concentrations of GBD stimulate fibroblast migration into such collagen matrices; and (b) fibronectin, as well as peptides containing all other of its functional domains, do not exhibit migration-stimulating activity when tested in the femtomolar to nanomolar concentration range (i.e. 0.1 pg/ml to 1 microgram/ml). The correct assignment of migration-stimulating activity to GBD, rather than to a contaminant, was confirmed by: (a) the use of several fibronectin and GBD purification protocols; (b) the neutralization of GBD migration-stimulating activity by monoclonal antibodies directed against epitopes present in this domain; (c) the time-dependent generation of migration-stimulating activity by the proteolytic degradation of native fibronectin; and (d) obtaining an identical dose-response curve with a genetically engineered GBD peptide. The cryptic migration-stimulating activity of GBD was not affected by the presence of serum or native fibronectin, but was inhibited by TGF-beta 1. Parallel experiments using the transmembrane assay confirmed that GBD was devoid of migration-stimulating activity in this assay when membranes coated with gelatin were used, but revealed that significant stimulation of migration was achieved with membranes coated with native type I collagen. Cells preincubated with GBD for 24 hours whilst growing on plastic tissue culture dishes and then plated onto native collagen matrices in the absence of further GBD also displayed an elevated migration compared to controls. Taken together, these observations suggest that: (a) the interaction of GBD with a putative cell surface receptor (and not the collagen substratum) initiates a persistent alteration in cell phenotype which is manifest by an increase in migratory activity when these cells are cultured on a native collagen substratum; and (b) GBD may play a hitherto unrecognised role in the control of cell migration in response to the local release of proteases during pathological processes, such as tumour invasion and wound repair.
先前有报道称,纳摩尔浓度的天然纤连蛋白及其含RGDS的细胞结合结构域在跨膜(或“博伊登室”)试验中可刺激成纤维细胞迁移;相比之下,纤连蛋白的明胶结合结构域(GBD)在该试验中一直被报道缺乏迁移刺激活性。我们在一个可能更具生理相关性的试验中,研究了纤连蛋白及其几个纯化的功能结构域对人皮肤成纤维细胞迁移的影响,该试验涉及细胞向天然I型胶原纤维的三维基质中移动。我们报告如下:(a)飞摩尔浓度的GBD可刺激成纤维细胞迁移到这种胶原基质中;(b)纤连蛋白以及含有其所有其他功能结构域的肽,在飞摩尔至纳摩尔浓度范围(即0.1 pg/ml至1微克/ml)进行测试时,未表现出迁移刺激活性。通过以下方式证实了将迁移刺激活性正确归因于GBD而非污染物:(a)使用多种纤连蛋白和GBD纯化方案;(b)用针对该结构域中存在的表位的单克隆抗体中和GBD的迁移刺激活性;(c)天然纤连蛋白经蛋白水解降解后,随时间产生迁移刺激活性;(d)用基因工程GBD肽获得相同的剂量反应曲线。GBD的隐蔽迁移刺激活性不受血清或天然纤连蛋白存在的影响,但受TGF-β1抑制。使用跨膜试验的平行实验证实,当使用涂有明胶的膜时,GBD在该试验中缺乏迁移刺激活性,但发现使用涂有天然I型胶原的膜可显著刺激迁移。在塑料组织培养皿上生长时预先用GBD孵育24小时,然后在没有进一步添加GBD的情况下接种到天然胶原基质上的细胞,与对照相比也表现出迁移增加。综上所述,这些观察结果表明:(a)GBD与假定的细胞表面受体(而非胶原基质)的相互作用引发细胞表型的持续改变,当这些细胞在天然胶原基质上培养时,表现为迁移活性增加;(b)在病理过程(如肿瘤侵袭和伤口修复)中,GBD可能在响应蛋白酶的局部释放而控制细胞迁移方面发挥迄今未被认识的作用。